Study to Evaluate HT-6184 in Healthy Subjects

Clinical trial NCT05447546 · COMPLETED

Trial details

NCT number: NCT05447546
Sponsor: Halia Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Normal Healthy Subjects

Start date: 2022-06-15
Primary completion: 2023-07-20
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.